Serum S100B Determination in the Management of Pediatric Mild Traumatic Brain Injury - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue Clinical Chemistry Année : 2012

Serum S100B Determination in the Management of Pediatric Mild Traumatic Brain Injury

Résumé

The place of serum S100B measurement in mild traumatic brain injury (mTBI) management is still controversial. Our prospective study aimed to evaluate its utility in the largest child cohort described to date.

Dates et versions

hal-01920073 , version 1 (12-11-2018)

Identifiants

Citer

Damien Bouvier, Mathilde Fournier, Jean-Benoît Dauphin, Flore Amat, Sylvie Ughetto, et al.. Serum S100B Determination in the Management of Pediatric Mild Traumatic Brain Injury. Clinical Chemistry, 2012, 58 (7), pp.1116 - 1122. ⟨10.1373/clinchem.2011.180828⟩. ⟨hal-01920073⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More